ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
2023 EHA® Insights: "Updated Results of the Ph1/2 VEN-A-QUI Study of Venetoclax + Quizartinib + Aza or LDAC in Newly Diagnosed Unfit AML Patients"
By
ecancer
FEATURING
Juan Miguel Bergua Burgues
By
ecancer
FEATURING
Juan Miguel Bergua Burgues
Comments 0
Login to view comments.
Click here to Login
